Corilagin acts by enhancing peripheral glucose utilization and stimulating pancreatic β cells to produce insulin [33] while myricetin enhances intracellular protein activity, encouraging glucose uptake consequently reduces insulin resistance [34, 35]. The gene discussed is INS; the disease is Insulin resistance.